Live: Will Axon Deliver Another Blowout Quarter After the Bell?
Live Updates
Axon Enterprise Coverage Wrap-Up
That wraps up our initial coverage of Axon’s Q1 results. Thank you for stopping by!
Stay tuned for more updates from management’s earnings call at 5 PM EST.
Axon’s First Quarter Suggests AI May Strengthen Its Moat, Not Destroy It
While many investors worry AI could commoditize software companies, Axon’s results suggest the opposite may be happening here. AI product revenue exploded more than 700% year over year as products like Draft One, Axon Assistant, Guardian, and AI-powered workflow tools gained traction across policing and public safety ecosystems.
What makes Axon difficult to disrupt is that its software sits on top of deeply embedded hardware relationships. Body cameras, TASER systems, fleet cameras, and evidence infrastructure are already installed across agencies worldwide. Competing AI software is far less useful if you do not control the underlying hardware, evidence chain, and data ecosystem.
That dynamic may help explain why Axon continues compounding like a software platform while maintaining one of the strongest competitive positions in public safety technology.
Axon Raises Outlook As AI Products Surge More Than 700%
Axon Enterprise (NASDAQ:AXON) reported strong Q1 results, with revenue rising 34% year over year to $807 million while the company raised its full-year growth outlook. Shares were modestly lower after hours despite the beat.
The bigger story was the acceleration inside Axon’s AI and software ecosystem. Software & Services revenue climbed 35% to $355 million, while AI product revenue surged more than 700% year over year. Annual recurring revenue also reached nearly $1.5 billion, up 35%, with net revenue retention holding at a strong 125%.
Management highlighted growing adoption of products like Draft One, Axon Assistant, and new AI-powered offerings unveiled at Axon Week, including Axon Vision and Axon Guardian. The company is increasingly positioning itself as an AI operating system for public safety rather than just a TASER and body camera company.
Another standout was Dedrone and drone-related products. Platform Solutions revenue jumped 95% year over year, while Dedrone revenue surged more than 300%, helped by rising interest in counter-drone systems ahead of major global events and new federal support under the Safer Skies Act.
Does the 2% Drop Make Sense?
Axon Enterprise (NASDAQ:AXON | AXON Price Prediction) shares are down 2% after a Q1 earnings report that beat on revenue ($807.4M vs $779.6M) and was effectively in line on adjusted EPS at $1.61 vs $1.60. Revenue growth of 34% tracks well above the FY guide of 27%-30%.
Historically, AXON beats averaged a +14.61% day-of move, while the lone miss drove a -9.43% drop. A 2% slip looks underwhelming against that backdrop, signaling the market viewed this as a thin EPS beat without the upside surprise that justifies a 262x P/E.
Investors are focused on guidance, not the headline. With YTD performance at -32.98%, the muted reaction makes sense pending tonight’s call commentary on the $6B 2028 framework.
Axon Earnings Are Out - Stock Down 2% After Results
Axon just reported earnings. Here are the key numbers:
Revenue: $807.4M vs. $779.6M expected
Adjusted EPS: $1.61 vs. $1.60 expected
Quick read:
Axon delivered another strong growth quarter, with revenue rising 34% year over year as demand for TASER devices, cloud software, and connected policing products remained strong.
Shares are initially down 2% following the report.
Axon's Insider Selling Stands Out Ahead Of Q1 Earnings Tonight
Axon’s Recent Insider Activity
Form 4 filings since February show 61 disposals and zero purchases, with sales clustered when shares traded near $579. CEO Patrick Smith and President Joshua Isner drove the bulk of dollar volume across early March.
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Feb 25 | P. Smith | CEO | Sale | 10,000 | $500.24 |
| Mar 10 | J. Isner | President | Sale | 7,390 | $530.27 |
| Apr 1 | C. Brooks | CRO | Sale | 5,849 | $423.57 |
| Mar 2 | B. Bagley | COO/CFO | Sale | 1,720 | $556.62 |
| Mar 3 | I. Fields | CLO | Sale | 775 | $579.09 |
The signal is muddied by 10b5-1 plans, yet the absence of any open-market buys at today’s $380.11 level, off 32.98% YTD, undercuts the conviction message.
What Analysts Are Watching Closely Ahead Of Axon's Q1 Earnings Tonight
Top 5 Analyst Questions
- Path to the $6 billion 2028 target given a 15% global tariff already baked into guidance.
- Carbyne integration cadence after its May 2026 close, plus Axon 911 monetization.
- Axon Assistant traction beyond 500 agencies and 200,000 monthly messages.
- Federal pipeline conversion and Dedrone as a new land-and-expand vector.
- Premium plan penetration past 30% of customers.
Red Flags to Watch Out For
- Adjusted gross margin slipping below 61.1%
- NRR easing from 125%
- Any softening of the 2028 framework
Guidance Is Everything for Axon's Q1 Earnings Tonight
Tonight’s Q1 results matter less than management’s guidance for Q2 and the back half of the year. Axon Enterprise (NASDAQ:AXON) entered 2026 guiding for revenue growth of 27% to 30% and an Adjusted EBITDA margin of 25.5%, with a $6 billion revenue target for 2028.
Management’s pattern is typically to give conservative guidance then raise. FY25 was lifted every quarter before landing at $2.78B. Investors want commentary on ARR ($1.35 billion, +35% YoY), NRR at 125%, and bookings of $14.4 billion.
What could make $AXON pop: raising the FY26 range above 30%, reaffirming the 2028 target, Q2 above consensus, and a margin guide above 25.5%.
What could send shares tumbling: trimming the range, NRR slipping under 120%, tariff pressure on margins, SBC above $620 million, or any softening of the $6B target. With shares down 32.98% YTD, tone on the call drives the reaction.
Bull vs Bear Case for Axon Ahead of Q1 Earnings
Bull Case
- Momentum is real: eighth straight quarter above 30% revenue growth, with NRR at 125% and ARR over $1.35B.
- Visibility is unusually strong: $14.4B future contracted bookings, up 43% YoY.
- AI flywheel is monetizing: ~$750M in AI Era Plan bookings with 500+ agencies live on Axon Assistant.
- Analyst conviction: 18 buys vs. 2 holds.
Bear Case
- Valuation remains rich at a P/E of 263 against decelerating 2026 guidance of 27%-30%.
- Execution risk is fresh: the Q3 2025 EPS miss of 24.08% drove an 8.19% one-day drop.
- Insiders are exiting, with 61 disposals and zero purchases since February.
- GAAP quality is weak: -$50.12M operating income and free cash flow down 31.03% YoY.
A Chance to Reset the Narrative
This quarter will determine whether the post-Q4 sell-off reflects doubt about the 2028 path or general multiple compression.
With a forward P/E near 49x and an average analyst price target of $701.76, analysts see a lot of upside for the stock.
A clean Q1 with NRR holding above 120% would likely help meaningfully for Axon’s sentiment.
Investors are watching Axon Enterprise (NASDAQ:AXON) ahead of its Q1 2026 results. After a blowout Q4 and bold full-year guidance, shares have slid roughly a third over the past twelve months, raising the stakes for management to defend its AI-led growth story this report.
From Earnings Beat to 33% YTD Decline
Last quarter, revenue rose 38.53% year over year to $796.7 million, topping consensus by 5.59%, while non-GAAP EPS of $2.15 beat the $1.60 estimate by 34.37%. Annual recurring revenue cleared $1.35 billion, net revenue retention hit 125%, and 2025 bookings reached $7.4 billion, up 46%. CFO Brittany Bagley called the 2026 setup “the strongest outlook we have had heading into the year.”
Yet the stock has fallen 13.99% since the February 24 filing and 38.75% over twelve months, trading near $375.60. Insiders sold across the C-suite from late February through April with no purchases recorded.
| Metric | Q1 2025 Actual | FY 2026 Guide |
|---|---|---|
| Revenue | $603.6M | +27% to +30% YoY |
| EPS (non-GAAP) | $1.41 | Not provided |
| Adj. EBITDA margin | n/a | 25.5% |
AI Adoption and Margins Will Set the Tone
I’ll be watching three things. First, the AI Era Plan ramp. President Joshua Isner said new product bookings nearly tripled to over $1 billion in 2025, with the AI Era Plan alone driving approximately $750 million. Axon Assistant is live at 500+ public safety agencies, generating 200,000+ messages per month. Sustained pace here would reinforce the software flywheel.
Second, margins. Bagley said the company has baked in a 15% global tariff, but Connected Devices revenue of $454.2 million (+37.6%) still carries exposure. With software margins above 80%, continued mix shift toward Software & Services, which grew 39.8% to $342.5 million in Q4, helps the story.
Third, integration. The Carbyne deal closed in Q1, bringing Carbyne into the Axon 911 stack. Investors are going to want to see early traction in bookings and cross-sell to Fusus customers. International revenue, currently around 19% of the mix, is another swing factor after international bookings crossed $1 billion for the first time in 2025.
Thomas Richmond is a financial writer and content strategist with 5+ years of experience covering stocks and financial markets. He has published over 250 articles focused on individual stock analysis, helping investors better understand business fundamentals, stock valuations, and long-term opportunities.
Thomas previously served as a Content Lead at TIKR, a stock research platform, where he helped scale the company’s blog to hundreds of articles per month and contributed to a weekly newsletter reaching more than 100,000 investors.
He specializes in breaking down complex companies into clear, actionable insights for everyday investors, with a focus on fundamentals-driven research.
His work has also been featured on platforms including Seeking Alpha and Sure Dividend.
Outside of work, Thomas enjoys weight lifting and soccer.
© 24/7 Wall St.